FIELD: organic chemistry.
SUBSTANCE: compound of Formula I, a pharmaceutical composition containing it, and the use of this compound or pharmaceutical composition in the therapy and/or prevention of a bacterial infection. In Formula I, A is selected from the group consisting of optionally substituted aryl, optionally substituted heterocyclyl, optionally substituted cycloalkyl, and optionally substituted alkenyl; R1 is independently selected from the group consisting of H and optionally substituted alkyl; L is ; Ra and Rb are the same or different from each other and are independently selected from the group consisting of H, halogen, optionally substituted alkyl, optionally substituted aryl, optionally substituted heteroalkyl and optionally substituted heteroaryl, and Ra and Rb may optionally be connected together to form a carbocyclic or heterocyclic ring; the remaining substituent values are as defined in the claims.
I
EFFECT: compound of Formula I with inhibitory activity against bacterial glutamyl cyclases (bacQC).
12 cl, 10 dwg, 5 tbl, 29 ex
Title | Year | Author | Number |
---|---|---|---|
QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | 2015 |
|
RU2760686C2 |
DERIVATIVE OF PYRIMIDINE AND A FIVE-MEMBERED NITROGEN-CONTAINING HETEROCYCLE, METHOD FOR PRODUCTION AND MEDICAL APPLICATIONS THEREOF | 2019 |
|
RU2775229C1 |
TRICYCLIC JANUS KINASE 1 INHIBITORS, COMPOSITIONS, METHODS OF PRODUCTION AND USE THEREOF | 2019 |
|
RU2824349C2 |
NEW DERIVATIVES OF IMIDAZO [4,5-C] QUINOLINES AND IMIDAZO [4,5-C] [1,5] NAPHTHYRIDINES AS LRRK2 INHIBITORS | 2016 |
|
RU2722149C1 |
NOVEL COMPOUNDS OF CONDENSED IMIDAZOLE POSSESSING OF CB2 RECEPTOR AGONIST PROPERTY | 2002 |
|
RU2312864C2 |
IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS TOLL-LIKE RECEPTOR AGONISTS | 2020 |
|
RU2785124C1 |
ANTIBODIES TO B7-H3 AND CONJUGATES OF ANTIBODY AND DRUG | 2017 |
|
RU2764651C2 |
AGONIST OF THE GLUCOCORTICOID RECEPTOR AND ITS IMMUNOCONJUGATES | 2017 |
|
RU2745748C2 |
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES | 2009 |
|
RU2504547C2 |
COLONY-STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS | 2016 |
|
RU2748884C2 |
Authors
Dates
2023-10-13—Published
2019-02-22—Filed